MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cerebral palsy"

  • 2026 International Congress

    IncobotulinumtoxinA for the Treatment of Lower Limb Spasticity in Children and Adolescents with Cerebral Palsy Evaluation of Lower Limb IncobotulinumtoxinA Efficacy (ELLIE)

    I. Makedonska (Dnipro, Ukraine)

    Objective: To investigate the use of incobotulinumtoxinA in the treatment of lower limb spasticity in children and adolescents with cerebral palsy (CP). Background: Spasticity associated…
  • 2026 International Congress

    Integrating Multidisciplinary, Family-Centered Care to Optimize Functional Outcomes in Children with Cerebral Palsy.

    T. Voloshyn (TRUSKAVETS, Ukraine)

    Objective: Optimal management of Cerebral Palsy requires coordinated, evidence-based interventions that address both motor and non-motor domains across the lifespan.  Background: Randomized controlled trials (RCTs)…
  • 2026 International Congress

    Effects of Manual Therapy on Hand Dexterity in Children Aged 4–8 Years: A Prospective Interventional Study

    TV. Voloshyn (TRUSKAVETS, Ukraine)

    Objective: This study aimed to evaluate the effect of a structured manual therapy program on hand dexterity in young children. Background: Impaired hand dexterity is…
  • 2025 International Congress

    The Burden of Spasticity in Adults with Cerebral Palsy in South Africa

    M. Noble, D. Veliotes, C. Dafkin (Parktown, South Africa)

    Objective: Describe the demographic profile of adults with Cerebral Palsy (CP) in South Africa (SA).Quantify the burden of spasticity in adults with CP.Investigate current spasticity…
  • 2024 International Congress

    ATP1A3-related disorder overlapping syndrome: a case report

    A. Santana, A. Azzoni, M. Sakuma, C. Gusmão (São Paulo, Brazil)

    Objective: The phenotypic spectrum in dystonic syndromes in ATP1A3-related disorders is wide. History of drug-refractory seizures, developemental delay, incoordination,  dysarthria and dysphagia and movement disorders…
  • 2024 International Congress

    Tetradystonics patients may be misdiagnosed?

    J. Duarte, H. Teive, F. Tensini, F. Germiniani (Curitiba, Brazil)

    Objective: Present a case of movement  disorder that genetic panel hasn’t tracked in the screening, and it’s stabilization with L-carnitine. Background: isobutyryl-CoA dehydrogenase deficiency is…
  • 2023 International Congress

    Efficacy and safety of deutetrabenazine in children and adolescents with dyskinesia in cerebral palsy

    D. Claassen, L. Dure, H. Barkay, S. Barash, G. Yiu, L. Voisin, L. Marinelli, P. Moshkov, J-M. Savola, M. Chen, N. Chaijale, M. Gordon, A. Ahn (Nashville, USA)

    Objective: To evaluate the efficacy and safety of deutetrabenazine (DTBZ) in children and adolescents with dyskinesia in cerebral palsy (DCP). Background: There are currently no…
  • 2023 International Congress

    Neuroimaging and correlation with functional status in children with cerebral palsy

    M. Ben Hafsa, H. Benrhouma, M. Jamoussi, T. Ben Younes, Z. Miladi, A. Zioudi, H. Klaa, I. Kraoua, S. Nagi, I. Ben Youssef-Turki (Tunis, Tunisia)

    Objective: To analyse the neuroimaging findings and to establish a correlation between clinical features and magnetic resonance imaging (MRI) patterns in children with cerebral palsy…
  • 2022 International Congress

    Safety of incobotulinumtoxinA in pediatrics: A pooled analysis

    F. Heinen, M. Banach, E. Dabrowski, D. Gaebler-Spira, H. Chambers, S. Schroeder, T. Geister, M. Althaus, A. Hanschmann, S. Berweck (Munich, Germany)

    Objective: To present analyses of pooled data on the safety of incobotulinumtoxinA (INCO) in pediatrics Background: BotulinumtoxinA (BoNT-A) is used to treat several conditions affecting…
  • 2022 International Congress

    Lack of immunogenicity of incobotulinumtoxinA in pediatrics: A pooled analysis

    F. Heinen, M. Banach, E. Dabrowski, D. Gaebler-Spira, H. Chambers, S. Schroeder, T. Geister, M. Althaus, A. Hanschmann, S. Berweck (Munich, Germany)

    Objective: To present pooled data analyses of the immunogenicity of incobotulinumtoxinA (INCO) in pediatrics. Background: BotulinumtoxinA (BoNT-A) is used to treat several chronic pediatric conditions,…
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley